Multispecific Targeting of Glioblastoma with Tumor Microenvironment-Responsive Multifunctional Engineered NK Cells

Scientists described a unique, sophisticated combinatorial platform for glioblastoma (GMB): a cooperative multifunctional immunotherapy based on genetically engineered human NK cells bearing multiple antitumor functions including local tumor responsiveness that addresses key drivers of GBM resistance to therapy.